ABL1 and cancer: In contrast to gene fusions involving protein kinases, such as the BCR-ABL fusion in chronic myeloid leukemia [21], therapeutic targets for cancers harboring gene fusion involving transcription factors are more elusive owed to their complex functions, as shown in this study.